Meeting Materials
Special Meeting Proxy Statement
View an enhanced version of our
Special Meeting Proxy Statement.
View an enhanced version of our
Special Meeting Proxy Statement.
YOUR VOTE IS IMPORTANT!
Please vote your proxy online now or by phone by
dialing 866-858-9058.
10:00 AM Montréal time
Friday, January 16, 2026
January 16, 2026 at 10:00 AM Montréal time
View an enhanced version of our
Annual Report.
View an enhanced version of our
Proxy Statement.
Request paper copies of the proxy materials online now, by email or by phone by dialing 866-648-8133.
Repare Therapeutics is a leading clinical-stage precision oncology company enabled by our proprietary synthetic lethality approach to discovering and developing novel therapeutics. We use our genome-wide, CRISPR-enabled SNIPRx® platform to systematically discover and develop highly targeted cancer therapies focused on genomic instability, including DNA damage repair.
Our company was founded in 2016 by field-leading academics to systematically employ synthetic lethality insights and platforms and develop new precision oncology medicines.